SOX11 as a minimal residual disease marker for Mantle cell lymphoma

Residual Disease ◽

Cell Lymphoma ◽

Disease Marker ◽

Mantle Cell ◽

Faculty Opinions recommendation of Cloned IGH VDJ targets as tools for personalized minimal residual disease monitoring in mature lymphoid malignancies; a feasibility study in mantle cell lymphoma by the Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717297959.792752812 ◽

2012 ◽

Author(s):

Nicolas Mounier

Keyword(s):

Mantle Cell Lymphoma ◽

Feasibility Study ◽

Residual Disease ◽

Cell Lymphoma ◽

Disease Monitoring ◽

Lymphoid Malignancies ◽

Minimal Residual Disease Monitoring ◽

Mantle Cell ◽

Minimal Residual Disease and Survival Outcomes in Patients with Mantle Cell Lymphoma: a systematic review and meta-analysis

Journal of Cancer ◽

10.7150/jca.51959 ◽

2021 ◽

Vol 12 (2) ◽

pp. 553-561

Author(s):

Yu Zhou ◽

Haizhu Chen ◽

Yunxia Tao ◽

Qiaofeng Zhong ◽

Yuankai Shi

Keyword(s):

Systematic Review ◽

Mantle Cell Lymphoma ◽

Residual Disease ◽

Cell Lymphoma ◽

Meta Analysis ◽

Survival Outcomes ◽

Mantle Cell ◽

Minimal residual disease in mantle cell lymphoma: are we ready for a personalized treatment approach?

Haematologica ◽

10.3324/haematol.2017.167627 ◽

2017 ◽

Vol 102 (7) ◽

pp. 1133-1136 ◽

Cited By ~ 9

Author(s):

Simone Ferrero ◽

Martin Dreyling

Keyword(s):

Mantle Cell Lymphoma ◽

Residual Disease ◽

Treatment Approach ◽

Cell Lymphoma ◽

Personalized Treatment ◽

Mantle Cell ◽

Pretransplant Minimal Residual Disease (MRD) Positivity Independently Predicts Survival in a Unselected Cohort of Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2014.11.179 ◽

2015 ◽

Vol 21 (2) ◽

pp. S131-S132

Author(s):

Andrew J. Cowan ◽

Philip A. Stevenson ◽

Ryan D. Cassaday ◽

Solomon A. Graf ◽

Leona Holmberg ◽

...

Keyword(s):

Stem Cell ◽

Complete Remission ◽

Stem Cell Transplantation ◽

Mantle Cell Lymphoma ◽

Residual Disease ◽

Cell Lymphoma ◽

Mantle Cell ◽

Minimal Residual ◽

Unselected Cohort

Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA study

Haematologica ◽

10.3324/haematol.2015.134957 ◽

2015 ◽

Vol 101 (3) ◽

pp. 336-345 ◽

Cited By ~ 18

Author(s):

M. Cheminant ◽

C. Derrieux ◽

A. Touzart ◽

S. Schmit ◽

A. Grenier ◽

...

Keyword(s):

Flow Cytometry ◽

Mantle Cell Lymphoma ◽

Residual Disease ◽

Cell Lymphoma ◽

Disease Monitoring ◽

Color Flow ◽

Minimal Residual Disease Monitoring ◽

Mantle Cell ◽

Potential loss of prognostic significance of minimal residual disease assessment after R‐CHOP‐based induction in elderly patients with mantle cell lymphoma in the era of rituximab maintenance

Hematological Oncology ◽

10.1002/hon.2550 ◽

2018 ◽

Vol 36 (5) ◽

pp. 773-778 ◽

Cited By ~ 3

Author(s):

Pavel Klener ◽

Eva Fronkova ◽

Marketa Kalinova ◽

David Belada ◽

Kristina Forsterova ◽

...

Keyword(s):

Elderly Patients ◽

Mantle Cell Lymphoma ◽

Residual Disease ◽

Cell Lymphoma ◽

Prognostic Significance ◽

Disease Assessment ◽

Rituximab Maintenance ◽

Mantle Cell ◽

Decision letter for "IMMUNOGLOBULIN KAPPA DELETING ELEMENT (IGK‐KDE) REARRANGEMENTS ARE CANDIDATE TARGETS FOR MINIMAL RESIDUAL DISEASE EVALUATION IN MANTLE CELL LYMPHOMA"

10.1002/hon.2792/v2/decision1 ◽

2020 ◽

Keyword(s):

Mantle Cell Lymphoma ◽

Residual Disease ◽

Cell Lymphoma ◽

Immunoglobulin Kappa ◽

Mantle Cell ◽

Review for "IMMUNOGLOBULIN KAPPA DELETING ELEMENT (IGK‐KDE) REARRANGEMENTS ARE CANDIDATE TARGETS FOR MINIMAL RESIDUAL DISEASE EVALUATION IN MANTLE CELL LYMPHOMA"

10.1002/hon.2792/v1/review1 ◽

2020 ◽

Keyword(s):

Mantle Cell Lymphoma ◽

Residual Disease ◽

Cell Lymphoma ◽

Immunoglobulin Kappa ◽

Mantle Cell ◽

Quantitative monitoring of cyclin D1 expression: A molecular marker for minimal residual disease monitoring and a predictor of the disease outcome in patients with mantle cell lymphoma

International Journal of Cancer ◽

10.1002/ijc.23883 ◽

2008 ◽

Vol 123 (12) ◽

pp. 2865-2870 ◽

Cited By ~ 14

Author(s):

Helena Brizova ◽

Marketa Kalinova ◽

Lenka Krskova ◽

Marcela Mrhalova ◽

Roman Kodet

Keyword(s):

Molecular Marker ◽

Mantle Cell Lymphoma ◽

Residual Disease ◽

Cell Lymphoma ◽

Disease Monitoring ◽

Minimal Residual Disease Monitoring ◽

Quantitative Monitoring ◽

Mantle Cell ◽

Mantle cell lymphoma: minimal residual disease outcomes

The Lancet Haematology ◽

10.1016/s2352-3026(20)30274-x ◽

2020 ◽

Vol 7 (11) ◽

pp. e775-e776

Author(s):

Julie M Vose

Keyword(s):

Mantle Cell Lymphoma ◽

Residual Disease ◽

Cell Lymphoma ◽

Disease Outcomes ◽

Mantle Cell ◽